DE60014887T3 - Analyseverfahren zur feststellung der prädisposition eines patienten auf mindesens eine erkrankung sowie geeignete amplifizierung für ein solches verfahren - Google Patents

Analyseverfahren zur feststellung der prädisposition eines patienten auf mindesens eine erkrankung sowie geeignete amplifizierung für ein solches verfahren Download PDF

Info

Publication number
DE60014887T3
DE60014887T3 DE60014887T DE60014887T DE60014887T3 DE 60014887 T3 DE60014887 T3 DE 60014887T3 DE 60014887 T DE60014887 T DE 60014887T DE 60014887 T DE60014887 T DE 60014887T DE 60014887 T3 DE60014887 T3 DE 60014887T3
Authority
DE
Germany
Prior art keywords
seq
drb1
fragments
alleles
probe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60014887T
Other languages
German (de)
English (en)
Other versions
DE60014887T2 (de
DE60014887D1 (de
Inventor
Bruno Mougin
Jean-Marie Tiercy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26234969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60014887(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9906599A external-priority patent/FR2793808B1/fr
Application filed by Biomerieux SA filed Critical Biomerieux SA
Application granted granted Critical
Publication of DE60014887D1 publication Critical patent/DE60014887D1/de
Publication of DE60014887T2 publication Critical patent/DE60014887T2/de
Publication of DE60014887T3 publication Critical patent/DE60014887T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60014887T 1999-05-20 2000-05-19 Analyseverfahren zur feststellung der prädisposition eines patienten auf mindesens eine erkrankung sowie geeignete amplifizierung für ein solches verfahren Expired - Lifetime DE60014887T3 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9906599A FR2793808B1 (fr) 1999-05-20 1999-05-20 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie
FR9906599 1999-05-20
FR9915314A FR2793809B1 (fr) 1999-05-20 1999-12-06 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede
FR9915314 1999-12-06
PCT/FR2000/001385 WO2000071750A1 (fr) 1999-05-20 2000-05-19 Procede d'analyse de la predisposition genetique d'un patient a au moins une maladie et amplification adaptee a un tel procede

Publications (3)

Publication Number Publication Date
DE60014887D1 DE60014887D1 (de) 2004-11-18
DE60014887T2 DE60014887T2 (de) 2005-10-13
DE60014887T3 true DE60014887T3 (de) 2009-09-24

Family

ID=26234969

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60014887T Expired - Lifetime DE60014887T3 (de) 1999-05-20 2000-05-19 Analyseverfahren zur feststellung der prädisposition eines patienten auf mindesens eine erkrankung sowie geeignete amplifizierung für ein solches verfahren

Country Status (12)

Country Link
US (1) US7060438B1 (enExample)
EP (1) EP1179091B2 (enExample)
JP (1) JP2003500067A (enExample)
CN (1) CN1351672A (enExample)
AT (1) ATE279535T1 (enExample)
AU (1) AU772175B2 (enExample)
BR (1) BR0010739A (enExample)
CA (1) CA2374440A1 (enExample)
DE (1) DE60014887T3 (enExample)
ES (1) ES2230109T5 (enExample)
FR (1) FR2793809B1 (enExample)
WO (1) WO2000071750A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2829580B1 (fr) 2001-09-07 2004-02-13 Bio Merieux Procede de lecture, de detection ou de quantification, hybrides ou complexes utilises dans ce procede et biopuce mettant en oeuvre ledit procede
WO2004047007A1 (en) 2002-11-15 2004-06-03 Bioarray Solutions, Ltd. Analysis, secure access to, and transmission of array images
EP1536021A1 (en) * 2003-11-27 2005-06-01 Consortium National de Recherche en Genomique (CNRG) Method for HLA typing
US7848889B2 (en) * 2004-08-02 2010-12-07 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
FR2881437B1 (fr) 2005-01-31 2010-11-19 Biomerieux Sa Procede pour le diagnostic/pronostic d'un syndrome septique
FR2906537A1 (fr) 2006-09-28 2008-04-04 Biomerieux Sa Procede de diagnostic in vitro du cancer broncho-pulmonaire par detection des transcrits majoritaires alternatifs du gene klk8 codant la kallicreine 8 et son utilisation pour le pronostic de survie
US20130096024A1 (en) * 2010-04-27 2013-04-18 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Method for detecting the susceptibility to develop adverse side effects related to bioimplants
EP2576815B1 (en) 2010-06-04 2018-02-14 Biomérieux Method for the prognosis of colorectal cancer
US9110079B2 (en) 2010-09-29 2015-08-18 Biomerieux Method and kit for establishing an in vitro prognosis on a patient exhibiting SIRS
WO2012129758A1 (en) 2011-03-25 2012-10-04 Biomerieux Method and kit for determining in vitro probability for individual to suffer from colorectal cancer
EP3000897B1 (en) 2013-05-21 2019-10-16 Biomérieux Colorectal cancer prognosis agent kit
EP3620984B1 (en) 2018-09-06 2024-04-10 Accenture Global Solutions Limited Digital quality control using computer visioning with deep learning
WO2025172242A1 (en) 2024-02-13 2025-08-21 bioMérieux Method of assessing the risk of death of a patient

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567809A (en) * 1986-03-13 1996-10-22 Hoffmann-La Roche Inc. Methods and reagents for HLA DRbeta DNA typing
US5468611A (en) * 1990-06-27 1995-11-21 The Blood Center Research Foundation, Inc. Method for HLA typing
NL9002259A (nl) * 1990-10-17 1992-05-18 Eurodiagnostics B V Werkwijze voor het bepalen van een genotype door het vergelijken van de nucleotidensequentie van leden van een genfamilie, alsmede kit voor het opsporen van genetische variaties.
GB9024005D0 (en) 1990-11-05 1990-12-19 British Bio Technology Process for amplifying nucleic acid
FR2679252B1 (fr) * 1991-07-17 1993-12-10 Bio Merieux Systeme de sondes permettant d'effectuer le typage hla dr, et procede de typage utilisant lesdites sondes.
US5976789A (en) * 1991-07-17 1999-11-02 Bio Merieux System of probes enabling HLA-DR typing to be performed, and typing method using said probes
JPH0690757A (ja) * 1991-08-23 1994-04-05 Kitasato Inst:The Ｈｌａ−ｄｒタイピング用塩基配列群とそれを用いた ｈｌａ−ｄｒタイピング法
JPH08308596A (ja) * 1995-03-10 1996-11-26 Wakunaga Pharmaceut Co Ltd Ｈｌａの検出
US5939542A (en) 1995-03-10 1999-08-17 Wakunaga Seiyaku Kabushiki Kaisha Detection of HLA-DR
WO1997020070A1 (en) * 1995-11-29 1997-06-05 The Anthony Nolan Bone Marrow Trust Methods for separating and/or identifying dna molecules
FR2749308B1 (fr) * 1996-06-03 1998-07-24 Bio Merieux Sondes nucleotidiques et procede pour determiner le typage hla dqb1
AU6321998A (en) * 1997-02-11 1998-08-26 William H. Hildebrand Class i sequence based typing of hla-a, -b, and -c alleles by direct dna sequencing
EP0887423A1 (en) * 1997-06-26 1998-12-30 Biotest Ag A method for determining the Histocompatibility locus antigen class II
JP2001512694A (ja) * 1997-08-11 2001-08-28 ビジブル・ジェネティクス・インコーポレーテッド Ｄｎａのｈｌａクラスｉタイプを決定するための方法およびキット
US5910413A (en) * 1997-10-10 1999-06-08 Visible Genetics, Inc. Method and kit for amplification, sequencing and typing of classical HLA class I genes

Also Published As

Publication number Publication date
EP1179091A1 (fr) 2002-02-13
AU772175B2 (en) 2004-04-08
ATE279535T1 (de) 2004-10-15
EP1179091B2 (fr) 2009-02-25
ES2230109T3 (es) 2005-05-01
EP1179091B1 (fr) 2004-10-13
BR0010739A (pt) 2002-02-19
AU4766000A (en) 2000-12-12
JP2003500067A (ja) 2003-01-07
FR2793809B1 (fr) 2006-07-28
FR2793809A1 (fr) 2000-11-24
US7060438B1 (en) 2006-06-13
CA2374440A1 (fr) 2000-11-30
WO2000071750A1 (fr) 2000-11-30
CN1351672A (zh) 2002-05-29
ES2230109T5 (es) 2009-06-05
DE60014887T2 (de) 2005-10-13
DE60014887D1 (de) 2004-11-18

Similar Documents

Publication Publication Date Title
DE60014887T3 (de) Analyseverfahren zur feststellung der prädisposition eines patienten auf mindesens eine erkrankung sowie geeignete amplifizierung für ein solches verfahren
DE69620791T2 (de) Verfahren zur auswertung polymorpher genetischer sequenzen, und dessen gebrauch zur bestimmung von hla-typen
DE60037584T2 (de) Auf microarrays basierende substraktive hybridisierung
DE69233458T2 (de) Nukleinsäuretypisierung durch polymeraseverlängerung von oligonukleotiden unter verwendung von terminator-mischungen
DE68926504T2 (de) Verfahren zur amplifizierung und zum nachweis von nukleinsäuresequenzen
DE69531831T2 (de) Verfahren mit einer hohen umsatzrate für das auffinden von sequenzen oder genetischen veränderungen in nukleinsäuren
DE69733958T2 (de) Verfahren zur positionierung von klonen mittels molekularen kaemmens
DE69527392T2 (de) Nachweis von Nukleinsäure-Amplifikation
DE69426956T2 (de) Nachweis von Mycobakterien durch Nukleinsäure-Multiplexamplifizierung
DE68926784T2 (de) Verfahren zur charakterisierung von hla dp
DE68929299T3 (de) Multiple genomische DNA-Verstärkung zum Nachweis einer Deletion
DE69329641T2 (de) Verfahren zur mehrfachen ligase-kettenreaktion
DE3486467T2 (de) Verfahren zum Nachweis, Identifizieren und Quantifizieren von Organismen und Viren
DE69937447T2 (de) Verfahren zur erkennung von nukleinsäuren
DE69328118T2 (de) Verbesserter strangverdrängungstest und dafür verwendbarer komplex
DE69026995T2 (de) Nukleinsäuresonden zum Nachweis von Lyme-Krankheit verursachenden Spirocheten
DE69026449T2 (de) Verfahren zur Diagnose und zur Amplifikation, das das Problem einer Fehlpaarung zwischen Primer und Zielsequenz am 3'-Ende des Primers überwindet
DE69003477T2 (de) Verfahren zum Nachweis von Nucleinsäuren.
DE112013004650T5 (de) Multiplexpyrosequenzierung unter Verwendung nichtinterferierender, rauschbeendender Polynukleotididentifikationstags
DE68923665T2 (de) Nachweis von Campylobacter.
DE60309817T2 (de) Mehrzweck-Primer und -Sonden für verbesserte Hybridisierungsassays durch Zerstörung von Sekundärstrukturen
DE69627625T2 (de) Die amplifizierung und bestimmung von arten des mycobakterium avium-komplexes
DE69628449T2 (de) Verfahren zur identifizierung unbekannter allele
DE69330463T2 (de) Isolierte nukleotid-sequenzen zum nachweis von neisseria gonorrhoeae
DE69022167T2 (de) Nukleinsäuresonden zum nachweis von staphylococcus aureus.

Legal Events

Date Code Title Description
8366 Restricted maintained after opposition proceedings